ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

Charles Sawyers to be New AACR President-Elect

March 23, 2012

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

August 11, 1989

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Environmental Carcinogenesis Seen As Next Big Growth Field; NCA Hears Problems, Priorities

October 31, 1975

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978